BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38156922)

  • 21. Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations.
    Al-Hashem F; Al-Humayed S; Amin SN; Kamar SS; Mansy SS; Hassan S; Abdel-Salam LO; Ellatif MA; Alfaifi M; Haidara MA; Al-Ani B
    J Cell Physiol; 2019 Jun; 234(6):9328-9337. PubMed ID: 30334569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of hypoxia-inducible factor-1α, regulated in development and DNA damage response-1 and mammalian target of rapamycin in human placental BeWo cells under hypoxia.
    Zhou F; Guan LB; Yu P; Wang XD; Hu YY
    Placenta; 2016 Sep; 45():24-31. PubMed ID: 27577706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.
    Pore N; Jiang Z; Shu HK; Bernhard E; Kao GD; Maity A
    Mol Cancer Res; 2006 Jul; 4(7):471-9. PubMed ID: 16849522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of AMPK α2 inhibits airway smooth muscle cells proliferation.
    Liu L; Pan Y; Song Y; Su X; Ke R; Yang L; Gao L; Li M
    Eur J Pharmacol; 2016 Nov; 791():235-243. PubMed ID: 27600020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/ HIF-1α pathway.
    Yu Y; Cai W; Zhou J; Lu H; Wang Y; Song Y; He R; Pei F; Wang X; Zhang R; Liu H; Wei F
    Int Immunopharmacol; 2020 Oct; 87():106830. PubMed ID: 32738596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoflurane preconditioning increases survival of rat skin random-pattern flaps by induction of HIF-1α expression.
    Sun Y; Li QF; Zhang Y; Hu R; Jiang H
    Cell Physiol Biochem; 2013; 31(4-5):579-91. PubMed ID: 23635649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
    Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
    Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen-rich solution alleviates acute radiation pneumonitis by regulating oxidative stress and macrophages polarization.
    Yin Z; Xu W; Ling J; Ma L; Zhang H; Wang P
    J Radiat Res; 2024 May; 65(3):291-302. PubMed ID: 38588586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling.
    Sheng B; Liu J; Li GH
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):51-8. PubMed ID: 22564403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
    Sudhagar S; Sathya S; Lakshmi BS
    Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METFORMIN MITIGATES SEPSIS-ASSOCIATED PULMONARY FIBROSIS BY PROMOTING AMPK ACTIVATION AND INHIBITING HIF-1α-INDUCED AEROBIC GLYCOLYSIS.
    Zhong H; Tang R; Feng JH; Peng YW; Xu QY; Zhou Y; He ZY; Mei SY; Xing SP
    Shock; 2024 Feb; 61(2):283-293. PubMed ID: 38010091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells.
    Gong J; Zhou S; Yang S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
    PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin inhibits the development and metastasis of colorectal cancer.
    Sugiura K; Okabayashi K; Seishima R; Ishida T; Shigeta K; Tsuruta M; Hasegawa H; Kitagawa Y
    Med Oncol; 2022 Jul; 39(9):136. PubMed ID: 35780231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.
    Li H; Satriano J; Thomas JL; Miyamoto S; Sharma K; Pastor-Soler NM; Hallows KR; Singh P
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F414-28. PubMed ID: 26136559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.